In Florida, drug-related death was the leading cause of pregnancy-associated death (PAD) in 2017, accounting for one in four deaths. In order to reduce PAD, it is important to identify women at greatest risk of PAD itself and its leading causes, including substance use disorder and associated mental health conditions (e.g., postpartum anxiety and depression). Florida provides a unique opportunity to examine the feasibility of screening tools for PAD and severe maternal morbidity (SMM), as it is the only state that currently requires universal screening of all pregnant women and infants. The Healthy Start (HS) Risk Screen, administered prenatally and at birth, identifies those at highest risk of preterm birth, low birth weight, adverse health outcomes, and infant mortality. The screening questions focus on sociocultural issues, reflecting aspects of health disparities and adversity that affect pregnancy, health, and infant development. These HS Risk Screens, either in their current form or enhanced to include other individual or environmental factors, may also be useful in identifying women at high risk of PAD and SMM. The goal of this study is to utilize the HS Risk Screens, along with other readily available data on individual and environmental factors, to examine the ability to identify women at risk of PAD and SMM, particularly related to postpartum anxiety, depression, and substance use disorder. We will use available linked statewide administrative data as well as leverage ongoing efforts to link these administrative datasets to the OneFlorida Data Trust, a central data repository that hosts electronic health records (EHR) and geospatial information for over 15 million patients across Florida. We will work closely with key stakeholders, including obstetric providers, the association of Healthy Start coalitions across Florida, and pregnant women, to determine the feasibility of prenatal screening for PAD and/or substance-use related SMM. Knowledge gained from this study will inform the feasibility of PAD and/or SMM screening at a large scale amongst diverse populations.

Public Health Relevance

In order to reduce pregnancy-associated death (PAD), it is important to identify women at greatest risk of PAD itself and its leading causes, including substance use disorder and associated mental health conditions (e.g., postpartum anxiety and depression). The goal of this study is to utilize the Florida Healthy Start Risk Screen, used to screen for adverse infant outcomes, along with other readily available data on individual and environmental factors, to examine the ability to identify women at risk of PAD and severe maternal morbidity. We will work closely with key stakeholders, including obstetric providers, the association of Healthy Start coalitions across Florida, and pregnant women, to determine the feasibility of prenatal screening for PAD and/or SMM.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR001427-06S1
Application #
10198171
Study Section
Program Officer
Brazhnik, Olga
Project Start
2020-09-01
Project End
2021-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
6
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Florida
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Chen, Zhiwei; He, Zhe; Liu, Xiuwen et al. (2018) Evaluating semantic relations in neural word embeddings with biomedical and general domain knowledge bases. BMC Med Inform Decis Mak 18:65
Weitzel, Kristin W; Smith, D Max; Elsey, Amanda R et al. (2018) Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons Learned. Clin Transl Sci 11:175-181
Amith, Muhammad; He, Zhe; Bian, Jiang et al. (2018) Assessing the practice of biomedical ontology evaluation: Gaps and opportunities. J Biomed Inform 80:1-13
Cavallari, Larisa H; Lee, Craig R; Beitelshees, Amber L et al. (2018) Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention. JACC Cardiovasc Interv 11:181-191
Sacharow, Stephanie J; Dudenhausen, Elizabeth E; Lomelino, Carrie L et al. (2018) Characterization of a novel variant in siblings with Asparagine Synthetase Deficiency. Mol Genet Metab 123:317-325
Sibille, Kimberly T; King, Christopher; Garrett, Timothy J et al. (2018) Omega-6: Omega-3 PUFA Ratio, Pain, Functioning, and Distress in Adults With Knee Pain. Clin J Pain 34:182-189
Smith, D Max; Weitzel, Kristin W; Cavallari, Larisa H et al. (2018) Clinical application of pharmacogenetics in pain management. Per Med 15:117-126
Baumert, Thomas F; Berg, Thomas; Lim, Joseph K et al. (2018) Status of Direct-acting Antiviral Therapy for HCV Infection and Remaining Challenges. Gastroenterology :
Zhang, Hansi; Guo, Yi; Li, Qian et al. (2018) An ontology-guided semantic data integration framework to support integrative data analysis of cancer survival. BMC Med Inform Decis Mak 18:41
Elding Larsson, Helena; Lynch, Kristian F; Lönnrot, Maria et al. (2018) Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children. Diabetologia 61:193-202

Showing the most recent 10 out of 602 publications